3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow BLI5100: new trials by email Literature Review of BLI5100 trials Research Report on BLI5100
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease BLI5100 - Non-erosive Reflux Disease, Erosive Esophagitis | Phase 3 | Completed | Braintree Laboratories | 400 | 2023-04-05 | 2025-09-26 |
| A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis BLI5100, PPI Control - Erosive Esophagitis | Phase 3 | Completed | Braintree Laboratories | 1250 | 2022-10-30 | 2026-06-16 |
| A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease BLI5100, Placebo - Non-erosive Reflux Disease | Phase 3 | Completed | Braintree Laboratories | 788 | 2022-09-06 | 2026-10-13 |
Non-Erosive Reflux Disease (2)
United States (3)
Leah Hollins (2)